Serum Inflammatory Markers and Dietary Inflammatory Index in Obese Individuals With Fatty Liver Disease: A Case–Control Study
Endocrinology, Diabetes & Metabolism · 2026
DOI: 10.1002/edm2.70181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, 2026. Verfasst von Faezeh Tejareh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Science and Research Branch, Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Obesity, C-Reactive Protein, Inflammation, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Fatty liver disease is common among obese individuals and is closely linked to chronic low‐grade inflammation. This study examines the relationship between dietary inflammatory index (DII) and serum inflammatory markers in obese individuals with and without non‐alcoholic fatty liver disease (NAFLD). Patients and Methods In this case–control study, 85 obese adults (BMI ≥ 30), aged 20–70 years, were recruited from two outpatient clinics in Urmia, Iran. NAFLD diagnosis was based on sonography by an endocrinologist. Serum C‐reactive protein (CRP) levels were measured using a high‐sensitivity immunoturbidimetric assay to assess systemic inflammation. Dietary intake was assessed using a validated semi‐quantitative food frequency questionnaire (FFQ). The Dietary Inflammatory Index (DII) was calculated to evaluate the inflammatory potential of the diet.
Results
Serum CRP levels were significantly higher in the NAFLD group (12.2 mg/L; 95% CI: 9.7–14.7) than controls (8.5 mg/L; 95% CI: 6.0–11.0; p = 0.04). DII scores did not differ significantly between groups ( p = 0.2). CRP was positively associated with NAFLD (OR = 2.89; 95% CI: 1.1–7.2), while DII showed no significant association (OR = 0.50; 95% CI: 0.2–1.2).
Conclusion
Our findings underscore the role of inflammation in the pathophysiology of fatty liver disease among obese individuals. Elevated CRP levels highlight potential targets for intervention. Although no significant differences in DII were observed, further serum investigation into the relationship between diet, inflammation and fatty liver is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition, Science and Research Branch, Islamic Azad University, Tehran, Iran.
- Medicinal Plants Research Center, Maragheh University of Medical Sciences, Maragheh, Iran.
- Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Seyed Ali Keshavarz
Zitieren
APA
Tejareh, F., Payahoo, L., & Keshavarz, S. A. (2026). Serum Inflammatory Markers and Dietary Inflammatory Index in Obese Individuals With Fatty Liver Disease: A Case–Control Study. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.70181
Vancouver
Tejareh F, Payahoo L, Keshavarz SA. Serum Inflammatory Markers and Dietary Inflammatory Index in Obese Individuals With Fatty Liver Disease: A Case–Control Study. Endocrinology, Diabetes & Metabolism. 2026. doi:10.1002/edm2.70181
BibTeX
@article{Tejareh2026,
author = {Tejareh, Faezeh and Payahoo, Laleh and Keshavarz, Seyed Ali},
title = {Serum Inflammatory Markers and Dietary Inflammatory Index in Obese Individuals With Fatty Liver Disease: A Case–Control Study},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2026},
doi = {10.1002/edm2.70181}
}
EUVIMED